Koning HK, a subsidiary of Koning Global
Koning HK, a subsidiary of Koning Global
Changing the World’s Perspective
on Breast Imaging
Our Mission
Our mission is to create a revolution in medical imaging through our advanced Computed Tomography technology, optimizing early disease detection, diagnosis, intervention and treatment. Our hope is to be able to improve survival rates and outcomes for millions of patients.
Our Vision
We believe our Koning Vera Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body. Our hope is to be able to improve survival rates and outcomes for millions of patients. We believe that the power, versatility and lower cost of Koning Vera Breast CT will serve as a viable substitute for many traditional imaging applications.
Koning Revolutionary Technology
2002
Dr. Ning founds Koning with exclusive
license from University of Rochester
Koning Corporation is founded as a Delaware C corporation and receives exclusive license from the University of Rochester for Cone Beam CT and Cone Beam Breast CT technology.
2006
Designs and starts clinical trials of first KBCT prototype
With the scientific and engineering experience from the previous cone beam CT systems, Dr. Ning and his group designed the first commercial grade Cone Beam Breast CT specifically for breast imaging.
2008
Secures $3.2M of US funding to accelerate development
2010
First clinical paper published showing positive results from 2006-2008 clinical trials
2018
Commercial version of KBCT approved by
CFDA
Regulatory approval recieved for Canada, Singapore, Australia, Thailand, and Qatar
